Earlier Thursday, Virios Therapeutics Said After FDA Guidance On The Plan To Progress IMC-1 To Phase 3 Study For Fibromyalgia, Several Life Science Companies Are Engaged, Reviewing Phase 2 Data And Proposed Phase 3 Program For A Potential Partnership
Benzinga Newsdesk - Nov 2, 2023, 10:58AM